Urol. praxi. 2025;26(3):138-143 | DOI: 10.36290/uro.2025.070

Technology of urodynamic testing and its benefits

MUDr. Pavel Drlík, Ph.D., MUDr. Lucie Bartáková
Urologická klinika 1. LF UK a ÚVN Praha

Urodynamic testing is a set of diagnostic methods to assess the function of the lower urinary tract during the filling and emptying phases of the bladder. In most cases, this is not a basic examination, but just a tip of the iceberg of testing methods in urology. These methods aid in diagnosing non-neurogenic and neurogenic causes of lower urinary tract dysfunction as well as in monitoring the effect of treatment in a parti­cular patient.

Keywords: bladder filling and emptying phase, urinary incontinence, micturition diary, uroglowmetry, cystometry.

Accepted: September 29, 2025; Published: October 17, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drlík P, Bartáková L. Technology of urodynamic testing and its benefits. Urol. praxi. 2025;26(3):138-143. doi: 10.36290/uro.2025.070.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 17.10.2026

    References

    1. Chapple C, Kelleher C, Siddiqui E, et al. Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB Outcomes. Eur Urol Focus. 2021;7(5):1176-1183. Go to original source... Go to PubMed...
    2. Malde S, Kelly S, Saad S, et al. Case-finding tools for the diagnosis of OAB in women: A narrative review. Neurourol Urodyn. 2020;39(1):13-24. Go to original source... Go to PubMed...
    3. Rosier PFWM, Schaefer W, Lose G, et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36(5):1243-1260. Go to original source... Go to PubMed...
    4. Brown JS, McNaughton KS, Wyman JF, et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology. 2003;61(4):802-809. Go to original source... Go to PubMed...
    5. Lukacz ES, DuHamel E, Menefee SA, et al. Elevated postvoid residual in women with pelvic floor disorders: prevalence and associated risk factors. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(4):397-400. Go to original source... Go to PubMed...
    6. Siroky MB, Olsson CA, Krane RJ. The flow rate nomogram: I. Development. J Urol. 1979;122(5):665-668. Go to original source... Go to PubMed...
    7. Working Group of the United Kingdom Continence Society; Abrams P, Eustice S, Gammie A, et al. United Kingdom Continence Society: Minimum standards for urodynamic studies, 2018. Neurourol Urodyn. 2019;38(2):838-856. Go to original source... Go to PubMed...
    8. Dörflinger A, Gorton E, Stanton S, Dreher E. Urethral pressure profile: is it affected by position? Neurourol Urodyn. 2002;21(6):553-557. Go to original source... Go to PubMed...
    9. Emberton M. Definition of at-risk patients: dynamic variables. BJU Int. 2006;97 Suppl 2:12-15. Go to original source... Go to PubMed...
    10. Mochtar CA, Kiemeney LA, van Riemsdijk MM, et al. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol. 2006;175(1):213-216. Go to original source... Go to PubMed...
    11. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14-15. Go to original source... Go to PubMed...
    12. Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7(Suppl 6):S14-21.
    13. Siroky MB, Olsson CA, Krane RJ. The flow rate nomogram: II. Clinical correlation. J Urol. 1980;123(2):208-210. Go to original source... Go to PubMed...
    14. Reynard JM, Peters TJ, Lim C, et al. The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol. 1996;77(6):813-818. Go to original source... Go to PubMed...
    15. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-178. Go to original source... Go to PubMed...
    16. Jeong SJ, Kim HJ, Lee YJ, et al. Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol. 2012;53(5):342-348. Go to original source... Go to PubMed...
    17. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93(6):745-750. Go to original source... Go to PubMed...
    18. Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl. 2004;(215):101-108. Go to original source... Go to PubMed...
    19. Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005;174(5):1887-1891. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.